References
- Gandhi J, Chen A, Dagur G, et al. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016;215(6):704–711. doi: 10.1016/j.ajog.2016.07.045.
- Monteleone P, Mascagni G, Giannini A, et al. Symptoms of menopause – global prevalence, physiology and implications. Nat Rev Endocrinol. 2018;14(4):199–215. doi: 10.1038/nrendo.2017.180.
- Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the international society for the study of women’s sexual health and the North American menopause society. Maturitas. 2014;79(3):349–354. doi: 10.1016/j.maturitas.2014.07.013.
- The 2020 genitourinary syndrome of menopause position statement of the North American menopause society. Menopause. 2020;27(9):976–992.
- Kagan R, Kellogg-Spadt S, Parish SJ. Practical treatment considerations in the management of genitourinary syndrome of menopause. Drugs Aging. 2019;36(10):897–908. doi: 10.1007/s40266-019-00700-w.
- Gold EB. The timing of the age at which natural menopause occurs. Obstet Gynecol Clin North Am. 2011;38(3):425–440. doi: 10.1016/j.ogc.2011.05.002.
- Mili N, Paschou SA, Armeni A, et al. Genitourinary syndrome of menopause: a systematic review on prevalence and treatment. Menopause. 2021;28(6):706–716. doi: 10.1097/GME.0000000000001752.
- Sturdee DW, Panay N, International Menopause Society Writing Group. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric. 2010;13(6):509–522. doi: 10.3109/13697137.2010.522875.
- Moral E, Delgado JL, Carmona F, et al. The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women. Menopause. 2018;25(12):1418–1423. doi: 10.1097/GME.0000000000001148.
- Faubion SS, Larkin LC, Stuenkel CA, et al. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from the North American menopause society and the international society for the study of women’s sexual health. Menopause. 2018;25(6):596–608. doi: 10.1097/GME.0000000000001121.
- Nappi RE, Palacios S, Panay N, et al. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE survey. Climacteric. 2016;19(2):188–197. doi: 10.3109/13697137.2015.1107039.
- Cox S, Nasseri R, Rubin RS, et al. Genitourinary syndrome of menopause. Med Clin North Am. 2023;107(2):357–369. doi: 10.1016/j.mcna.2022.10.017.
- Kingsberg SA, Wysocki S, Magnus L, et al. Vulvar and vaginal atrophy in postmenopausal women: findings from the revive (REal women’s views of treatment options for menopausal vaginal Changes) survey. J Sex Med. 2013;10(7):1790–1799. doi: 10.1111/jsm.12190.
- Wysocki S, Kingsberg S, Krychman M. Management of vaginal atrophy: implications from the revive survey. Clin Med Insights Reprod Health. 2014;8:23–30. doi: 10.4137/CMRH.S14498.
- Frank SM, Ziegler C, Kokot-Kierepa M, et al. Vaginal health: insights, views & attitudes (VIVA) survey – Canadian cohort. Menopause Int. 2013;19(1):20–27. doi: 10.1258/mi.2012.012034.
- Kingsberg SA, Krychman M, Graham S, et al. The women’s empower survey: identifying women’s perceptions on vulvar and vaginal atrophy and its treatment. J Sex Med. 2017;14(3):413–424. doi: 10.1016/j.jsxm.2017.01.010.
- Chua Y, Limpaphayom KK, Cheng B, et al. Genitourinary syndrome of menopause in five asian countries: results from the Pan-Asian REVIVE survey. Climacteric. 2017;20(4):367–373. doi: 10.1080/13697137.2017.1315091.
- Erekson EA, Yip SO, Wedderburn TS, et al. The vulvovaginal symptoms questionnaire: a questionnaire for measuring vulvovaginal symptoms in postmenopausal women. Menopause. 2013;20(9):973–979. doi: 10.1097/GME.0b013e318282600b.
- Srisukho S, Pantasri T, Piyamongkol W, et al. The experience of genitourinary syndrome of menopause (GSM) among Thai postmenopausal women: the non-reporting issue. Int Urogynecol J. 2019;30(11):1843–1847. doi: 10.1007/s00192-019-03991-0.
- Palma F, Volpe A, Villa P, et al. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: the AGATA study. Maturitas. 2016;83:40–44. doi: 10.1016/j.maturitas.2015.09.001.
- Zhang L, Ruan X, Cui Y, et al. Menopausal symptoms among Chinese peri- and postmenopausal women: a large prospective single-center cohort study. Gynecol Endocrinol. 2021;37(2):185–189. doi: 10.1080/09513590.2020.1832070.
- Selvi I, Baydilli N, Yuksel D, et al. Reappraisal of the definition criteria for "genitourinary syndrome of menopause," and its effect on quality of life in turkish postmenopausal women. Urology. 2020;144:83–91. doi: 10.1016/j.urology.2020.07.025.
- Simon JA, Kokot-Kierepa M, Goldstein J, et al. Vaginal health in the United States: results from the vaginal health: insights, views & attitudes survey. Menopause. 2013;20(10):1043–1048. doi: 10.1097/GME.0b013e318287342d.
- Nappi RE, Kokot-Kierepa M. Vaginal health: insights, views & attitudes (VIVA) – results from an international survey. Climacteric. 2012;15(1):36–44. doi: 10.3109/13697137.2011.647840.
- Nappi RE, Kokot-Kierepa M. Women’s voices in the menopause: results from an international survey on vaginal atrophy. Maturitas. 2010;67(3):233–238. doi: 10.1016/j.maturitas.2010.08.001.
- Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015;175(4):531–539. doi: 10.1001/jamainternmed.2014.8063.
- Ng KL, Ng KWR, Thu WPP, et al. Risk factors and prevalence of urinary incontinence in mid-life Singaporean women: the integrated women’s health program. Int Urogynecol J. 2020;31(9):1829–1837. doi: 10.1007/s00192-019-04132-3.
- Cipriani S, Simon JA. Sexual dysfunction as a harbinger of cardiovascular disease in postmenopausal women: how far are We? J Sex Med. 2022;19(9):1321–1332. doi: 10.1016/j.jsxm.2022.06.007.
- Roushias S, Ossei-Gerning N. Sexual function and cardiovascular disease: what the general cardiologist needs to know. Heart. 2019;105(2):160–168. doi: 10.1136/heartjnl-2016-310762.